6 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... week) >1 year #Cryptococcal ... Meningoencephalitis #IDSA ... #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... mg/kg per day) plus ... year B-III #Cryptococcal ... Meningoencephalitis #IDSA
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... mg/kg IV daily plus ... mg/kg IV daily plus ... Cryptococcosis #Cryptococcus ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... are achieved; plus ... Cytomegalovirus #CMV #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Adolescent ARV Guidelines ... Tuberculosis #TB #IDSA ... opportunistic #infections #HIVAIDS
Cryptococcal meningitis on T2 MRI
30 M from sub-Saharan Africa presents w/ progressive Headache x1 mo, +neck
Cryptococcal meningitis ... Cryptococcal meningitis ... amphotericin B) plus ... B deoxycholate plus ... Guidelines recommend